Valve in Valve transcatheter mitral valve replacement by a transvenous, transseptal access: A case report

Jiafu Wei; Fei Chen; Wei Meng; Xin Wei; Yong Peng; Qiao LI; Sen HE; Yijian LI; Mingxia Zheng; Xuan Zhou; Guo Chen; Yuan Feng; Mao Chen

Return

Valve in Valve transcatheter mitral valve replacement by a transvenous, transseptal access: A case report

VernacularTitle:股静脉-房间隔途径经导管二尖瓣置换术一例
Author: Jiafu WEI ¹ ; Fei CHEN ¹ ; Wei MENG ² ; Xin WEI ¹ ; Yong PENG ¹ ; Qiao LI ¹ ; Sen HE ¹ ; Yijian LI ¹ ; Mingxia ZHENG ¹ ; Xuan ZHOU ³ ; Guo CHEN ⁴ ; Yuan FENG ¹ ; Mao CHEN ¹
Author Information

1. Department of Vasculocardiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
2. Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
3. Department of Radiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
4. Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
Publication Type:Journal Article
Keywords: Mitral valve replacement; transseptal; transvenous; transcatheter; Valve-in-Valve
From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2021;28(01):122-124
CountryChina
Language:Chinese
Abstract: Reoperation due to degenerated bioprostheses is an important factor of high-risk thoracic surgeries. In 2020 ACC/AHA guideline, Valve in Valve (ViV) was recommended for high-risk patient instead of surgical mitral valve replacement. This report described a 77-year-old male patient with a failed mitral bioprosthetic valve, evaluated at high risk of surgery, received a transvenous, transseptal transcatheter mitral valve replacement (TMVR). Tracheal intubation was removed at CCU 3 h after surgery without discomfort such as polypnea. The patient was transferred out of the CCU and discharged on the 3rd day. Compared with transapical access, transvenous transseptal access was less invasive, with shorter duration in CCU and hospitalization.